Company · CIK 1703057 # AbCellera Biologics Inc. Source: SEC EDGAR · as of 2026-10-27 06:30 UTC · latest filing day 2026-10-26 | CIK | [1703057](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001703057) (SEC EDGAR) | | --- | --- | | Industry (SIC) | 2834 — Pharmaceutical Preparations | | Incorporated in | A1 | | Business address | British Columbia, Canada | | Listed | ABCL (Nasdaq) | | First annual or quarterly report | 2021-03-30 | ## Offerings 4 registrations | Registration | Label and status | First filed | Last event | Filings | | --- | --- | --- | --- | --- | | 333-285367 | Shelf Effective | 2025-02-27 | 2026-08-13 | 3 | | 333-256998 | Registered company Effective | 2021-06-10 | 2022-08-11 | 3 | | 333-263047 | Shelf Effective | 2022-02-25 | 2022-02-25 | 1 | | 333-250838 | IPO Final prospectus | 2020-11-20 | 2020-12-14 | 6 | ## Filings 14 | Filed | Filing | Registration | Accession | | --- | --- | --- | --- | | 2026-08-13 | [424B5](https://www.sec.gov/Archives/edgar/data/1703057/000119312526349333/0001193125-26-349333-index.htm) Shelf takedown | 333-285367 | 0001193125-26-349333 | | 2026-08-11 | [424B5](https://www.sec.gov/Archives/edgar/data/1703057/000119312526344944/0001193125-26-344944-index.htm) Shelf takedown | 333-285367 | 0001193125-26-344944 | | 2025-02-27 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1703057/000119312525039391/0001193125-25-039391-index.htm) Shelf registered | 333-285367 | 0001193125-25-039391 | | 2022-08-11 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1703057/999999999522002331/9999999995-22-002331-index.htm) Declared effective | 333-256998 | 9999999995-22-002331 | | 2022-02-25 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1703057/000114036122006833/0001140361-22-006833-index.htm) Shelf registered | 333-263047 | 0001140361-22-006833 | | 2021-06-21 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1703057/999999999521002431/9999999995-21-002431-index.htm) Declared effective | 333-256998 | 9999999995-21-002431 | | 2021-06-10 | [S-1](https://www.sec.gov/Archives/edgar/data/1703057/000119312521187930/0001193125-21-187930-index.htm) Registration filed | 333-256998 | 0001193125-21-187930 | | 2020-12-14 | [424B4](https://www.sec.gov/Archives/edgar/data/1703057/000119312520316986/0001193125-20-316986-index.htm) Final prospectus | 333-250838 | 0001193125-20-316986 | | 2020-12-10 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1703057/999999999520003483/9999999995-20-003483-index.htm) Declared effective | 333-250838 | 9999999995-20-003483 | | 2020-12-10 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1703057/000119312520314458/0001193125-20-314458-index.htm) Amendment | 333-250838 | 0001193125-20-314458 | | 2020-12-07 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1703057/000119312520311091/0001193125-20-311091-index.htm) Amendment | 333-250838 | 0001193125-20-311091 | | 2020-11-25 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1703057/000119312520302988/0001193125-20-302988-index.htm) Amendment | 333-250838 | 0001193125-20-302988 | | 2020-11-20 | [S-1](https://www.sec.gov/Archives/edgar/data/1703057/000119312520299507/0001193125-20-299507-index.htm) Registration filed | 333-250838 | 0001193125-20-299507 | | 2020-10-05 | [DRS](https://www.sec.gov/Archives/edgar/data/1703057/000095012320010081/0000950123-20-010081-index.htm) Draft made public | 377-03630 | 0000950123-20-010081 | [All filings of this company](https://equitycapital.markets/filings?cik=1703057) · [CSV](https://equitycapital.markets/filings.csv?cik=1703057) --- Source page: https://equitycapital.markets/company/1703057 · Data: U.S. SEC EDGAR · CC BY 4.0